IGC IGC
Company Profile ↓Company Overview
IGC (IGC) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Mar 2025 Revenue of $1.27M (-5.5% YoY); net profit $-7.12M.
- Trailing 12 Months Year-on-year growth — revenue -5.5%.
- 5-Year Trend Long-term compounding — revenue CAGR -8.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -7.98% |
| 1 Year: | -5.50% |
Stock Price Performance
| 1 Year: | -28.00% |
| 6 Months: | -6.67% |
| 3 Months: | -21.25% |
| 1 Month: | -10.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)38.07 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -8.0% CAGR over 5 years.
- Trading 46.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2013 | Dec 2013 | Jun 2014 | Sep 2014 | Dec 2014 | Jun 2015 | Sep 2015 | Dec 2015 | Jun 2016 | Sep 2016 | Dec 2016 | Jun 2017 | Sep 2017 | Dec 2017 | Jun 2018 | Sep 2018 | Dec 2018 | Jun 2019 | Sep 2019 | Dec 2019 | Jun 2020 | Sep 2020 | Dec 2020 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.13M | 17.53K | 763.86K | 2.12M | 2.54M | 1.86M | 2.06M | 1.08M | 288.49K | 162.16K | 249.80K | 52.93K | 235.00K | 762.00K | 1.48M | 811.00K | 1.28M | 1.65M | 1.82M | 573.00K | 584.00K | 125.00K | 108.00K | 77.00K | 56.00K | 142.00K | 212.00K | 202.00K | 332.00K | 555.00K | 291.00K | 204.00K | 272.00K | 412.00K | - | 330.00K | 328.00K | 191.00K | 350.00K | 317.00K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 176.00K | 174.00K | 92.00K | 306.00K | 262.00K |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.00K | 42.00K | 18.00K | 45.00K | 41.00K | 28.00K | 30.00K | 46.00K | 26.00K | 14.00K | 26.00K | 38.00K | 62.00K | 142.00K | 135.00K | 102.00K | 255.00K | 174.00K | 133.00K | 163.00K | 198.00K | - | 154.00K | 154.00K | 99.00K | 44.00K | 55.00K |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.57M | 2.06M | 3.00M | 2.98M | 2.51M |
| Operating Income | -432.71K | -294.02K | -1.15M | -765.28K | -499.15K | -257.34K | -508.22K | -375.00K | -318.81K | -549.63K | -386.11K | -396.27K | -263.00K | -473.00K | -511.00K | -855.00K | -1.58M | -1.46M | -1.29M | -1.68M | -1.93M | -1.68M | -2.33M | -2.19M | -4.35M | -2.38M | -2.80M | -2.49M | -2.28M | -2.14M | -2.49M | -3.00M | -2.40M | -1.76M | - | -1.41M | -1.91M | -2.90M | -2.94M | -2.46M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.26M | -1.76M | -2.78M | -2.88M | -2.40M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.20M | -1.60M | -1.82M | -726.00K | -2.40M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -615.19K | -310.48K | -1.20M | -887.40K | -590.11K | -382.70K | -623.37K | -403.00K | -383.57K | -583.87K | -111.56K | -432.14K | -304.00K | -532.58K | -512.00K | -859.00K | -1.15M | -1.38M | -1.18M | -1.60M | -1.88M | -1.66M | -2.32M | -1.79M | -4.34M | -2.38M | -2.79M | -2.44M | -2.25M | -2.08M | -2.45M | -5.59M | -2.38M | -1.72M | - | -1.20M | -1.60M | -1.82M | -726.00K | -2.40M |
| Diluted EPS | -0.09 | -0.04 | -0.12 | -0.07 | -0.05 | -0.03 | -0.04 | -0.02 | -0.02 | -0.02 | 0.00 | -0.02 | -0.01 | -0.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.05 | -0.09 | -0.03 | -0.02 | -0.02 | - | -0.02 | -0.02 | - | -0.02 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | 56.54K | 78.00K | 0 | 36.00K | 278.00K | 166.00K | 247.00K | 222.00K | 295.00K | 222.00K | 219.00K | 154.00K | 444.00K | 276.00K | 377.00K | 1.39M | 768.00K | 806.00K | 747.00K | 1.27M | 903.00K | 889.00K | 917.00K | 852.00K | 997.00K | 851.00K | 1.59M | - | 1.27M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.07M | 4.20M | 8.03M | 2.27M | 7.68M | 6.37M | 580.37K | 2.19M | 5.12M | 4.07M | 898.00K | 397.00K | 911.00K | 1.34M | 1.27M |
| Gross Profit | - | - | - | - | - | - | 218.24K | 82.00K | 132.00K | 115.00K | 113.00K | 194.00K | 442.00K | 733.00K | 619.00K |
| Operating Income | -15.89M | -7.51M | -2.48M | -2.53M | -4.34M | -2.91M | -2.05M | -1.79M | -4.64M | -6.86M | -8.72M | -15.43M | -11.57M | -9.80M | -7.45M |
| Net Income | -20.24M | -7.75M | -2.25M | -3.02M | -4.61M | -2.81M | -1.87M | -1.79M | -4.10M | -7.32M | -8.81M | -15.02M | -11.51M | -13.00M | -7.12M |
| Diluted EPS | -1.34 | -2.66 | -0.32 | -0.37 | -0.31 | -0.17 | -0.07 | - | - | - | - | - | - | -0.22 | -0.09 |
| R&D Expense | - | - | - | - | - | - | - | 137.00K | 1.26M | 1.01M | 929.00K | 2.33M | 3.46M | 3.77M | 3.65M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 18.16M | 25.26M | 19.25M | 17.73M | 20.33M | 18.86M | 11.28M | 10.85M | 34.47M | 28.98M | 35.87M | 26.83M | 17.18M | 9.90M | 8.75M |
| Total Equity | 26.15M | 6.67M | 14.84M | 14.44M | 13.63M | 14.23M | 13.48M | 7.36M | 8.06M | 33.57M | 26.54M | 32.80M | 23.89M | 14.91M | 7.32M | 6.33M |
| Cash & Equivalents | 842.92K | 1.58M | 562.95K | 1.06M | 1.03M | 824.49K | 1.49M | 538.00K | 1.66M | 25.61M | 7.26M | 14.55M | 10.46M | 3.20M | 1.20M | 405.00K |
| Long Term Debt | - | - | - | - | 0 | 323.90K | 801.47K | 452.08K | - | - | 0 | 276.00K | 144.00K | 141.00K | 137.00K | 134.00K |
| Total Liabilities | - | 7.79M | 9.44M | 4.28M | 3.59M | 5.58M | 4.91M | 3.93M | 2.79M | 893.00K | 2.45M | 3.06M | 2.94M | 2.27M | 2.58M | 2.42M |
| Current Liabilities | - | 6.58M | 4.50M | 1.82M | 1.03M | 2.45M | 3.20M | 1.29M | 2.35M | 878.00K | 1.95M | 2.37M | 2.44M | 1.90M | 2.34M | 2.26M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.63M | -5.02M | 564.85K | -1.74M | -2.58M | -157.70K | -1.39M | -1.93M | -3.33M | -8.68M | -10.80M | -7.46M | -7.05M | -5.20M | -4.79M |
| Investing Cash Flow | -44.70K | 4.67M | -74.70K | 3.08K | -518.09K | -183.42K | -241.35K | -657.00K | -260.00K | -9.55M | 3.39M | -742.00K | -235.00K | -317.00K | -442.00K |
| Financing Cash Flow | 3.41M | -625.76K | 27.69K | 1.74M | 2.90M | 1.01M | 707.56K | 3.71M | 27.60M | -59.00K | 14.69M | 4.14M | 100.00K | 3.52M | 4.45M |
| Capital Expenditure | -285.44K | -5.48K | -326.08K | -8.48K | -76.53K | -122.19K | -145.68K | -136.00K | -15.00K | -4.39M | -1.47M | -236.00K | -310.00K | -138.00K | -112.00K |
| Free Cash Flow | -2.92M | -5.03M | 238.77K | -1.75M | -2.66M | -279.89K | -1.54M | -2.07M | -3.35M | -13.07M | -12.27M | -7.70M | -7.36M | -5.34M | -4.91M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | 37.6% | 3.7% | 2.6% | 2.8% | 12.6% | 48.9% | 48.5% | 54.5% | 48.7% |
| Operating Margin % | -390.0% | -178.9% | -30.9% | -111.2% | -56.5% | -45.6% | -354.0% | -81.6% | -90.8% | -168.6% | -971.5% | -3,886.1% | -1,270.1% | -728.5% | -585.8% |
| Net Margin % | -496.8% | -184.6% | -28.0% | -133.0% | -60.1% | -44.1% | -321.7% | -81.4% | -80.1% | -179.6% | -981.2% | -3,782.4% | -1,263.0% | -966.5% | -560.3% |
| ROE % | -303.6% | -52.2% | -15.6% | -22.2% | -32.4% | -20.8% | -25.4% | -22.1% | -12.2% | -27.6% | -26.9% | -62.8% | -77.2% | -177.6% | -112.5% |
| ROCE % | -137.1% | -36.2% | -14.3% | -15.1% | -24.3% | -18.6% | -20.6% | -21.0% | -13.8% | -25.4% | -26.0% | -63.2% | -75.7% | -129.6% | -114.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IGC
IGC Pharma puts AI tools on display for Alzheimer’s research in London - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPejVaRmctYnZvbmt5M1hKeWFWQVhock0xTkFPSmZWalhiSFF5bHhQRE94SHRKVjdhYmNtaTQtemlTbkFodHdrbkt4WW9NM2VOdU9SZ2VnNXlOVXMxd3pDNnZNZ1dRVlhfRVBqN3ZFVkpReTBMc1NhYy1SNlVWcHNDT3FScC1EV0QzbjJabk…
IGC|IGC Pharma Inc|Price:0.248|Chg%:-0.001 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBnOGRhNFdJa1RidmdDMlg4RGlhLXY2Z0pHMHRaa002bjdRZmVubXhJMF9FLUl6dHB0M0ZIQjN3aGdIMzdmbFNrMUZqUnpXYVE4eDdra2xGYklfWFZFSU9rVXVEN2poQ3g4R3ZEeQ?oc=5" target="_blank">IGC|IGC Pharma Inc|Pr…
IGC Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE1ETE5FQjNhWHppNTZqZU1RZlVqNU93TkdHNWJ2TFhBd3Y2aDlXVUlFRTdYT19nYTJKX3BjSWN2Z0oycG1EYmhWWVlVSjAxOXB5TDAzczBFS1ZJd3h0bV83VFA4bndmc28tUVQ1ZDI4VGVKc3pHR2c?oc=5" target="_blank">IGC Fore…
IGC Pharma, New to The Street launch 12-part national media partnership - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPTW1md0dvTGhsNzlKMFY5Z0t4VDRFZjdpNzdTNllZZXVEV2drWmNoT19qRmg4Z2R3X0hlQTZURmN6Z0R5UllERmdzU24tcy16UFpfTll6ZDFTMGttLU84OUxSdjFic3BKRndIb2pGNEVBdExwTnZUODVMM0J2Y1B3dFZwNnAzZVFIeDdpYU…
IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment - BioSpace
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOQ1c0WDhEajllZUJvVl82dWhkcEM3S1FKcGl1YmN1Q1NuMGV3TTR4dHRQMWE1c1hBSVFHYUJ5V1VyRy1VNnN6LWZlVkx0S1I4THRHUWtaWFpxVjVaa2EyUzlVd3pVZmJyS3BjOExlUjE4ckJYNUxER3MxY3FtLVZjR3J5Sk5BSjNPc0NURU…
IGC Pharma earnings beat, revenue topped estimates - Investing.com
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxObzd5Qy16VmhaVHRlZjYxSVBzOFFGLVQ0QlU3Sy1NTGMwR1BmdVVrSTNEbWZBRHl3aTFJLTZ3UjJzRFVVaWZ4SXFiX20tMnF5THRNcmZaVFk1VW44MTM5NV9SZnNkU2d1MWhDLVdtaDBIbDBLTVQ0ZHdjRlNST2c3SjBhbTNldXhMWW5ONm…
IGC — Frequently Asked Questions
What is the current share price of IGC?
As of 2026-08-05 17:25 PDT, IGC trades at $0.25 on NASDAQ/NYSE. Its 52-week range is $0.24 to $0.47.
What is the P/E ratio of IGC?
IGC trades at a trailing price-to-earnings (P/E) ratio of -2.78.
What is the return on equity (ROE) of IGC?
IGC has a return on equity (ROE) of -112.51%. Its return on capital employed (ROCE) is -114.73%.
Is IGC a good stock to buy?
This page provides a data-driven analysis of IGC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.